{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:55:37Z","timestamp":1777395337744,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173896"],"award-info":[{"award-number":["82173896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LJ201601"],"award-info":[{"award-number":["LJ201601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpba.2025.116943","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T14:44:41Z","timestamp":1746369881000},"page":"116943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Establish a simple LC-MS\/MS method for the determination of MRX-8 by employing dried blood spots in rat pharmacokinetic study"],"prefix":"10.1016","volume":"264","author":[{"given":"Xingyi","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxue","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beining","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2025.116943_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/phar.1510","article-title":"To B or not to B, that is the question: is it time to replace colistin with polymyxin B?","volume":"35","author":"Kassamali","year":"2015","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.jpba.2025.116943_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1586\/14787210.2015.1093933","article-title":"Polymyxin B versus colistin: an update","volume":"13","author":"Cai","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"2","key":"10.1016\/j.jpba.2025.116943_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9673(01)00585-4","article-title":"Isolation and structural characterization of polymyxin B components","volume":"912","author":"Orwa","year":"2001","journal-title":"J. Chromatogr. A"},{"issue":"11","key":"10.1016\/j.jpba.2025.116943_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01517-20","article-title":"Pharmacodynamic evaluation of MRX-8, a novel polymyxin, in the neutropenic mouse thigh and lung infection models against gram-negative pathogens","volume":"64","author":"Lepak","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.jpba.2025.116943_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00139-22","article-title":"In vitro potency and spectrum of the novel polymyxin MRX-8 tested against clinical isolates of gram-negative bacteria","volume":"66","author":"Duncan","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.jpba.2025.116943_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11121711","article-title":"Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road","volume":"11","author":"Aslan","year":"2022","journal-title":"Antibiotics"},{"issue":"4","key":"10.1016\/j.jpba.2025.116943_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13040354","article-title":"Pharmacokinetics and nephrotoxicity of polymyxin MRX-8 in rats: a novel agent against resistant gram-negative bacteria","volume":"13","author":"Qu","year":"2024","journal-title":"Antibiotics"},{"key":"10.1016\/j.jpba.2025.116943_bib8","article-title":"In vitro activity of MRX-8 and comparators against clinical isolated gram-negative Bacilli in China","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jpba.2025.116943_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121911","article-title":"Instantaneous monitoring of free sarin in whole blood by dry blood spot-thermal desorption-GC-FPD\/MS analysis","volume":"1136","author":"Marder","year":"2020","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.jpba.2025.116943_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10040248","article-title":"Dried blood spot in laboratory: directions and prospects","volume":"10","author":"Malsagova","year":"2020","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.jpba.2025.116943_bib11","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1515\/cclm-2019-1062","article-title":"The re-emergence of dried blood spot sampling - are we ready?","volume":"57","author":"Zakaria","year":"2019","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.jpba.2025.116943_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jchromb.2008.05.025","article-title":"Application of dried blood spots combined with HPLC-MS\/MS for the quantification of acetaminophen in toxicokinetic studies","volume":"870","author":"Barfield","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.jpba.2025.116943_bib13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jac\/dks536","article-title":"A validated ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of polymyxin B in mouse serum and epithelial lining fluid: application to pharmacokinetic studies","volume":"68","author":"He","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2025.116943_bib14","unstructured":"Q2(R2) Validation of Analytical Procedures. \u3008https:\/\/www.gmp-compliance.org\/gmp-news\/ich-guidance-q14-q2r2-analytical-method-development-method-validation-published-for-consultation\u3009."},{"key":"10.1016\/j.jpba.2025.116943_bib15","unstructured":"ICH guideline M10 on bioanalytical method validation and study sample analysis. \u3008https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf\u3009."},{"key":"10.1016\/j.jpba.2025.116943_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123129","volume":"1191","author":"Wang","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"12","key":"10.1016\/j.jpba.2025.116943_bib17","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/jps.22709","article-title":"A convenient method to measure blood-plasma concentration ratio using routine plasma collection in in vivo pharmacokinetic studies","volume":"100","author":"Berezhkovskiy","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.116943_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jpba.2017.02.046","article-title":"Dried blood spots combined to an UPLC-MS\/MS method for the simultaneous determination of drugs of abuse in forensic toxicology","volume":"147","author":"Sadler Sim\u00f5es","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116943_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2021.06.014","article-title":"Hematocrit and standardization in DBS analysis: a practical approach for hormones mainly present in the plasma fraction","volume":"520","author":"Ackermans","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jpba.2025.116943_bib20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jpba.2018.10.010","article-title":"Is the hematocrit still an issue in quantitative dried blood spot analysis?","volume":"163","author":"Velghe","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2025.116943_bib21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1208\/s12248-010-9188-y","article-title":"Use of dried blood spots in drug development: pharmacokinetic considerations","volume":"12","author":"Rowland","year":"2010","journal-title":"Aaps J."},{"key":"10.1016\/j.jpba.2025.116943_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ame2.12041","article-title":"Reference values for selected hematological, biochemical and physiological parameters of Sprague-Dawley rats at the Animal House, Faculty of Medicine, University of Colombo, Sri Lanka","author":"Delwatta","year":"2018","journal-title":"Animal Model Exp. Med."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:38:30Z","timestamp":1748889510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":22,"alternative-id":["S0731708525002845"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116943","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establish a simple LC-MS\/MS method for the determination of MRX-8 by employing dried blood spots in rat pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116943","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116943"}}